(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEUROCRINE BIOSCIENCES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NEUROCRINE BIOSCIENCES

ST13

US500000090980266

Class

5, 42, 44

Filing

90980266

Registration

7243484

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

08/19/2026

Trademark type

Combined

Nice classes

5, 42, 44

Filing date

08/16/2021

Registration date

12/12/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/12/2023

Last transaction

08/19/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/26/2023

First use in commerce

06/19/2023

Drawing code

3

Owner type

03

Owner location

San Diego, CA, US

Examiner

CHHINA, KARANENDRA S

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a stylized circular spiral design with "NEUROCRINE" above "BIOSCIENCES" in block lettering to the right.

Holders and representatives

Holders

Neurocrine Biosciences, Inc.

Representatives

Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for human use for treatment of tardive dyskinesia; Pharmaceutical preparations for the treatment of psychiatricneurologicalcentral nervous systemmovement diseasesdisorders and conditions

Class 42

Research and development services in the fields of pharmaceuticals and biotechnology; pharmaceutical drug development services in the field of psychiatricneurologicalcentral nervous systemmovement diseasesdisorders and conditions

Class 44

Providing medical information; providing medical information in the field of psychiatricneurologicalcentral nervous systemmovement diseasesdisorders and conditions; on-line information servicesproviding medical information in the field of psychiatricneurologicalcentral nervous systemmovement diseasesdisorders and conditions

Publications

History of USPTO decisions and trademark events.

40 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

08/19/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/20/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/20/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/20/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/20/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/20/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/20/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/20/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/20/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/22/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/22/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/22/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/12/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/12/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/04/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/03/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/17/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/16/2023

DPCC

DIVISIONAL PROCESSING COMPLETE

08/16/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/09/2023

IUAF

USE AMENDMENT FILED

07/20/2023

DRRR

DIVISIONAL REQUEST RECEIVED

07/20/2023

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

07/20/2023

EISU

TEAS STATEMENT OF USE RECEIVED

07/20/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/07/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/13/2022

PUBO

PUBLISHED FOR OPPOSITION

12/13/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/23/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/05/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/05/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/04/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/04/2022

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

05/05/2022

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

05/05/2022

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

05/05/2022

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

05/05/2022

DOCK

ASSIGNED TO EXAMINER

05/03/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/06/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/05/2021

NWAP

NEW APPLICATION ENTERED

08/19/2021

Continuous trademark protection

Get notified about every new filing that threatens NEUROCRINE BIOSCIENCES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.